Suchergebnisse - "McLean, Chelsea"

PubPharm (34)

1

Safety and Immunogenicity of Accelerated Heterologous Two-dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Mwesigwa, B. | Sawe, F. | Oyieko, J. | +34

2

Safety and Immunogenicity of the Heterologous 2-Dose Ad26.ZEBOV, MVA-BN-Filo Vaccine Regimen in Health Care Providers and Frontliners of the Democratic Republic of the Congo

enthalten in: The Journal of infectious diseases | 2024

von Larivière, Y. | Garcia-Fogeda, I. | Zola Matuvanga, T. | +14

3

Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen : A phase 3, randomized, double-blind, placebo-controlled trial

enthalten in: Human vaccines & immunotherapeutics | 2024

von Goldstein, N. | McLean, C. | Gaddah, A. | +7

4

Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo : secondary and exploratory outcomes of an open-label, randomised, phase 2 trial

enthalten in: The Lancet. Infectious diseases | 2024

von Larivière, Y. | Matuvanga, T. | Osang'ir, B. | +13

5

Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola : A single-arm, open-label Phase II clinical trial in Kenya and Uganda

enthalten in: Vaccine | 2023

von Man-Lik Choi, E. | Abu-Baker Mustapher, G. | Omosa-Manyonyi, G. | +24

6

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants : a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

enthalten in: The Lancet. Global health | 2023

von Choi, E. | Lacarra, B. | Afolabi, M. | +137

CommentIn: Lancet Glob Health. 2023 Nov;11(11):e1672-e1673. - PMID 37858573

7

Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola

enthalten in: NPJ vaccines | 2023

von Alexandre, M. | Prague, M. | McLean, C. | +8

8

Identification of early gene expression profiles associated with long-lasting antibody responses to the Ebola vaccine Ad26.ZEBOV/MVA-BN-Filo

enthalten in: Cell reports | 2023

von Blengio, F. | Hocini, H. | Richert, L. | +8

9

The histone methyltransferase DOT1L prevents antigen-independent differentiation and safeguards epigenetic identity of CD8⁺T cells

enthalten in: bioRxiv.org | 2023

von Kwesi-Maliepaard, E. | Aslam, M. | Alemdehy, M. | +14

10

Immune response of a two-dose heterologous Ebola vaccine regimen : summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory

enthalten in: EBioMedicine | 2023

von McLean, C. | Barry, H. | Kieh, M. | +24